Interleukin-21 in immune and allergic diseases

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 4, 2012, Pages 313-319

  Sarra, Massimiliano ^a   Laura Cupi, Maria ^a   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

IBD; IL 21; IL 21R

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 21; STAT3 PROTEIN;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE THYROIDITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CROHN DISEASE; ENTERITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; UPREGULATION; VASCULITIS;

ANIMALS; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM DISEASES; INFLAMMATION; INTERLEUKINS; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-21;

EID: 84869748863     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812800959040     Document Type: Article

References (73)

1. Spolski, R.; Leonard, W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol, 2008, 26, 57-79.
2. Spolski, R.; Leonard, W.J. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol, 2008, 20(3), 295-301.
3. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol, 2011, 29, 621-663.
4. Fina, D.; Fantini, M.C.; Pallone, F.; Monteleone, G. Role of interleukin-21 in inflammation and allergy. Inflamm. Allergy Drug Targets, 2007, 6(1), 63-68.
5. Habib, T.; Senadheera, S.; Weinberg, K.; Kaushansky, K. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry, 2002, 41(27), 8725-8731.
6. Asao, H.; Okuyama, C; Kumaki, S.; Ishii, N.; Tsuchiya, S.; Foster, D.; Sugamura, K. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol, 2001, 167(1), 1-5.
7. Pelletier, M.; Bouchard, A.; Girard D. In vivo and in vitro roles of IL-21 in inflammation. J. Immunol, 2004, 173(12), 7521-7530.
8. Brandt, K.; Bulfone-Paus, S.; Foster, D.C.; Rückert, R. Interleukin- 21 inhibits dendritic cell activation and maturation. Blood, 2003, 102(12), 4090-4098.
9. MacDonald, T.T.; Bell, I.; Monteleone, G. The opposing roles of IL-21 and TGFp1 in chronic nflammatory bowel disease. Biochem. Soc. Trans., 2011, 39(4), 1061-1066.
10. Sarra, M.; Monteleone, I.; Stolfi, C; Fantini, M.C.; Sileri, P.; Sica, G.; Tersigni, R.; Macdonald T.T.; Pallone, F.; Monteleone, G. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm. Bowel Dis., 2010, 16(8), 1332-1339.
11. Monteleone, G.; Monteleone, I.; Fina, D.; Vavassori, P.; Del Vecchio Blanco, G.; Caruso, R.; Tersigni, R.; Alessandroni, L.; Biancone, L.; Naccari, G.C.; MacDonald, T.T.; Pallone, F. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology, 2005,128(3), 687-694.
12. Caruso, R.; Fina, D.; Peluso, I.; Stolfi, C; Fantini, M.C.; Gioia, V.; Caprioli, F.; Del Vecchio Blanco, G.; Paoluzi, O.A.; Macdonald, T.T.; Pallone, F.; Monteleone, G. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells. Gastroenterology, 2007, 132(1), 166-175.
13. Monteleone, G.; Caruso, R.; Fina, D.; Peluso, I.; Gioia, V.; Stolfi, C; Fantini, M.C.; Caprioli, F.; Tersigni, R.; Alessandroni, L.; MacDonald, T.T.; Pallone, F. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut, 2006, 55(12), 1774-1780.
14. Fina, D.; Sarra, M.; Fantini, M.C.; Rizzo, A.; Caruso, R.; Caprioli, F.; Stolfi, C; Cardolini, I.; Dottori, M.; Boirivant, M.; Pallone, F.; Macdonald, T.T.; Monteleone, G. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology, 2008, 134(4), 1038-1048.
15. Stolfi, C.; Rizzo, A.; Franzè, E.; Rotondi, A.; Fantini, M.C.; Sarra, M.; Caruso, R.; Monteleone, I.; Sileri, P.; Franceschilli, L.; Caprioli, F.; Ferrero, S.; MacDonald, T.T.; Pallone, F.; Monteleone, G. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J. Exp. Med., 2011, 208(11), 2279-2290.
16. Jauch, D.; Martin, M.; Schiechl, G.; Kesselring, R.; Schlitt, H.J.; Geissler, E.K.; Fichtner-Feigl, S. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Gut, 2011, 60(12), 1678-1686.
17. Rizzo, A.; Pallone, F.; Monteleone, G.; Fantini, M.C. Intestinal inflammation and colorectal cancer: a double-edged sword? World J. Gastroenterol., 2011, 17(26), 3092-3100.
18. Fina, D.; Sarra, M.; Caruso, R.; Del Vecchio Blanco, G.; Pallone, F.; MacDonald, T.T.; Monteleone, G. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut, 2008,57(7), 887-892.
19. Bodd, M.; Ráki, M.; Tollefsen, S.; Fallang, L.E.; Bergseng, E.; Lundin, K.E.; Sollid, L.M. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol., 2010,3(6), 594-601.
20. Caruso, R.; Fina, D.; Peluso, I.; Fantini, M.C.; Tosti, C.; Del Vecchio Blanco, G.; Paoluzi, O.A.; Caprioli, F.; Andrei, F.; Stolfi, C.; Romano, M.; Ricci, V.; MacDonald, T.T.; Pallone, F.; Monteleone, G. IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol., 2007, 178(9), 5957-5965.
21. Tsokos, G.C. Systemic lupus erythematosus. N. Engl. J. Med., 2011, 365(22), 2110-2121
22. Sawalha, A.H.; Kaufman, K.M.; Kelly, J.A.; Adler, A.J.; Aberle, T.; Kilpatrick, J.; Wakeland, E.K.; Li, Q.Z.; Wandstrat, A.E.; Karp, D.R.; James, J.A.; Merrill, J.T.; Lipsky, P.; Harley, J.B. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis., 2008, 67(4), 458-461.
23. Wong, C.K.; Wong, P.T.; Tam, L.S.; Li, E.K.; Chen, D.P.; Lam, C.W. Elevated Production of B Cell Chemokine CXCL13 is Correlated with Systemic Lupus Erythematosus Disease Activity. J. Clin. Immunol., 2010, 30, 45-52.
24. Caruso, R.; Botti, E.; Sarra, M.; Esposito, M.; Stolfi, C.; Diluvio, L.; Giustizieri, M.L.; Pacciani, V.; Mazzotta, A.; Campione, E.; Macdonald, T.T.; Chimenti, S.; Pallone, F.; Costanzo, A.; Monteleone, G. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med., 2009, 15(9), 1013-1015.
25. Vinuesa, C.G.; Cook, M.C.; Angelucci, C.; Athanasopoulos, V.; Rui, L.; Hill, K.M.; Yu, D.; Domaschenz, H.; Whittle, B.; Lambe, T.; Roberts, I.S.; Copley, R.R.; Bell, J.I.; Cornall, R.J.; Goodnow, C.C. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature, 2005, 435(7041), 452-458.
26. Ozaki, K.; Spolski, R.; Ettinger, R.; Kim, H.P.; Wang, G.; Qi, C.F.; Hwu, P.; Shaffer, D.J.; Akilesh, S.; Roopenian, D.C.; Morse, H.C.; Lipsky, P.E.; Leonard, W.J. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol., 2004, 173(9), 5361-5371.
27. Monteleone, G.; Pallone, F.; Macdonald T.T. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease. Cytokine Growth Factor Rev., 2009, 20(2), 185-91.
28. Bubier, J.A.; Bennett, S.M.; Sproule, T.J.; Lyons, B.L.; Olland, S.; Young, D.A.; Roopenian, D.C. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann. N. Y. Acad. Sci., 2007, 1110, 590-601.
29. Bubier, J.A.; Sproule, T.J.; Foreman, O.; Spolski, R.; Shaffer, D.J.; Morse, H.C. 3rd; Leonard, W.J.; Roopenian, D.C. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. U S A., 2009,106(5), 1518-1523.
30. Herber, D.; Brown, T.P.; Liang, S.; Young, D.A.; Collins, M.; Dunussi-Joannopoulos, K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 2007, 178(6), 3822-3830.
31. Odegard, J.M.; Marks, B.R.; Di Placido, L.D.; Poholek, A.C.; Kono, D.H.; Dong, C.; Flavell, R.A.; Craft, J. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med., 2008, 205(12), 2873-2886.
32. Rankin, A.L.; Guay, H.; Herber, D.; Bertino, S.A.; Duzanski, T.A.; Carrier, Y.; Keegan, S.; Senices, M.; Stedman, N.; Ryan, M.; Bloom, L.; Medley, Q.; Collins, M.; Nickerson-Nutter, C; Craft, J.; Young, D.; Dunussi-Joannopoulos, K. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. J. Immunol, 2012, 188(4), 1656-1667.
33. Nestle, F. O.; Kaplan, D. H.; Barker, J. Psoriasis. N. Engl. J. Med., 2009, 361, 496-509.
34. Nestle, F. O.; Di, M. P.; Qin J. Z.; Nickoloff, B. J. Skin immune sentinels in health and disease. Nat. Rev. Immunol, 2009, 9, 679-691.
35. Liu, Y.; Helms, C; Liao, W.; Zaba, L.C.; Duan, S.; Gardner, J.; Wise, C; Miner, A.; Malloy, M.J.; Pullinger, C.R.; Kane, J.P.; Saccone, S.; Worthington, J.; Bruce, I.; Kwok, P.Y.; Menter, A.; Krueger, J.; Barton, A.; Saccone, N.L.; Bowcock, A.M. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet, 2008, 4(3):e1000041.
36. Livden, J.K.; Nilsen, R.; Bjerke, J.R.; Matre, R. In situ localization of interferons in psoriatic lesions. Arch. Dermatol. Res., 1989, 281(6), 392-397.
37. Strengell, M.; Julkunen, I.; Matikainen, S. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells. J. Leukoc. Biol, 2004, 76(2), 416-422.
38. Sarra, M.; Caruso, R.; Cupi, M.L.; Monteleone, I.; Stolfi, C; Campione, E.; Diluvio, L.; Mazzotta, A.; Botti, E.; Chimenti, S.; Costanzo, A.; MacDonald, T.T.; Pallone, F.; Monteleone, G. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-y-dependent epidermal hyperplasia. J. Immunol, 2011, 186(9), 5435-5442.
39. Novak, N.; Leung, D.Y. Advances in atopic dermatitis. Curr. Opin. Immunol, 2011, 23(6), 778-783.
40. Jin, H.; Oyoshi, M.K.; Le, Y.; Bianchi, T.; Koduru, S.; Mathias, C.B.; Kumar, L.; Le Bras, S.; Young, D.; Collins, M.; Grusby, M.J.; Wenzel, J.; Bieber, T.; Boes, M.; Silberstein, L.E.; Oettgen, H.C.; Geha, R.S. IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J. Clin. Invest., 2009, 119(1), 47-60.
41. Gallagher, M.P.; Goland, R.S.; Greenbaum, C.J. Making progress: preserving beta cells in type 1 diabetes. Ann. N. Y. Acad. Sci., 2011, 1243, 119-134.
42. Asano, K.; Ikegami, H.; Fujisawa, T.; Nishino, M.; Nojima, K.; Kawabata, Y.; Noso, S.; Hiromine, Y.; Fukai, A.; Ogihara, T. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes. Hum. Immunol, 2007, 68(5), 384-391.
43. King, C; Ilic, A.; Koelsch, K.; Sarvetnick, N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell, 2004, 117(2), 265-277.
44. McGuire, H.M.; Vogelzang, A.; Hill, N.; Flodström-Tullberg, M.; Sprent, J.; King, C. Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc. Natl Acad. Sci. U S A., 2009, 106(46), 19438-19443.
45. Spolski, R.; Kashyap, M.; Robinson, C; Yu, Z.; Leonard, W.J. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA., 2008, 105(37), 14028-14033.
46. Datta, S.; Sarvetnick, N.E. IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS One, 2008, 3, e3118.
47. McGuire, H.M.; Vogelzang, A.; Ma, C.S.; Hughes, W.E.; Silveira, P.A.; Tangye, S.G. Christ, D.; Fulcher, D.; Falcone, M.; King, C. A subset of interleukin-21 + chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity. Immunity, 2011, 34(4), 602-615.
48. Paczesny, S.; Hanauer, D.; Sun, Y.; Reddy, P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant, 2010, 45(1), 1-11.
49. Haase, D.; Starke, M.; Puan, K.J.; Lai, T.S.; Rotzschke, O. Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD. Immunol. Res., 2012, [Epub ahead of print].
50. Hippen, K.L.; Bucher, C; Schirm, D.K.; Bearl, A.M.; Brender, T.; Mink, K.A.; Waggie, K.S.; Peffault de Latour, R.; Janin, A.; Curtsinger, J.M.; Dillon, S.R.; Miller, J.S.; Socie, G.; Blazar, B.R. Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood, 2012, 119(2), 619-628.
51. Meguro, A.; Ozaki, K.; Oh, I.; Hatanaka, K.; Matsu, H.; Tatara, R.; Sato, K.; Leonard, W.J.; Ozawa, K. IL-21 is critical for GVHD in a mouse model. Bone Marrow Transplant., 2010, 45(4), 723-729.
52. Bucher, C.; Koch, L.; Vogtenhuber, C.; Goren, E.; Munger, M.; Panoskaltsis-Mortari, A.; Sivakumar, P.; Blazar, B.R. IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation. Blood, 2009, 114(26), 5375-5384.
53. Oh, I.; Ozaki, K.; Meguro, A.; Hatanaka, K.; Kadowaki, M.; Matsu, H.; Tatara, R.; Sato, K.; Iwakura, Y.; Nakae, S.; Sudo, K.; Teshima, T.; Leonard, W.J.; Ozawa, K. Altered effector CD4 T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease. J. Immunol., 2010, 185(3), 1920-1926.
54. Meguro, A.; Ozaki, K.; Hatanaka, K.; Oh, I.; Sudo, K.; Ohmori, T.; Matsu, H.; Tatara, R.; Sato, K.; Sakata, Y.; Nakae, S.; Leonard, W.J.; Ozawa, K. Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells. Bone Marrow Transplant., 2011, 46(12), 1557-1565.
55. Hanash, A.M.; Kappel, L.W.; Yim, N.L.; Nejat, R.A.; Goldberg, G.L.; Smith, O.M.; Rao, U.K.; Dykstra, L.; Na, I.K.; Holland, A.M.; Dudakov, J.A.; Liu, C.; Murphy, G.F.; Leonard, W.J.; Heller, G.; Van den Brink, M.R. Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL. Blood, 2011, 118(2), 446-455.
56. McInnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med., 2011, 365(23), 2205-2219.
57. Jüngel, A.; Distler, J.H.; Kurowska-Stolarska, M.; Seemayer, C.A.; Seibl, R.; Forster, A.; Michel, B.A.; Gay, R.E.; Emmrich, F.; Gay, S.; Distler, O. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum., 2004, 50(5), 1468-1476.
58. Niu, X.; He, D.; Zhang, X.; Yue, T.; Li, N.; Zhang, J.Z.; Dong, C.; Chen, G. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum. Immunol., 2010, 71(4), 334-341.
59. Li, J.; Shen, W.; Kong, K.; Liu, Z. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J. Immunol., 2006, 64(5), 515-522.
60. Andersson, A.K.; Feldmann, M.; Brennan, F.M. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Scand J. Immunol., 2008, 68(1), 103-111.
61. Young, D.A.; Hegen, M.; Ma, H.L.; Whitters, M.J.; Albert, L.M.; Lowe, L.; Senices, M.; Wu, P.W.; Sibley, B.; Leathurby, Y.; Brown, T.P.; Nickerson-Nutter, C.; Keith, J.C.; Collins, M. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum., 2007, 56(4), 1152-1163.
62. Jang, E.; Cho, S.H.; Park, H.; Paik, D.J.; Kim, J.M.; Young, J. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J. Immunol., 2009, 182(8), 4649-4656.
63. Kang, K.Y.; Kim, H.O.; Kwok, S.K.; Ju, J.H.; Park, K.S.; Sun, D.I.; Jhun, J.Y.; Oh, H.J.; Park, S.H.; Kim, H.Y. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res. Ther., 2011, 13(5), R179.
64. Distler, J.H.; Jüngel, A.; Kowal-Bielecka, O.; Michel, B.A.; Gay, R.E.; Sprott, H.; Matucci-Cerinic, M.; Chilla, M.; Reich, K.; Kalden, J.R.; Müller-Ladner, U.; Lorenz, H.M.; Gay, S.; Distler, O. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum, 2005, 52(3), 856-864.
65. Terrier, B.; Geri, G.; Chaara, W.; Allenbach, Y.; Rosenzwajg, M.; Costedoat-Chalumeau, N.; Fouret, P.; Musset, L.; Benveniste, O.; Six, A.; Klatzmann, D.; Saadoun, D.; Cacoub, P. IL-21 modulates Th1 and Th17 responses in giant cell arteritis. Arthritis Rheum., 2011, doi: 10.1002/art.34327. [Epub ahead of print].
66. Geri, G.; Terrier, B.; Rosenzwajg, M.; Wechsler, B.; Touzot, M.; Seilhean, D.; Tran, T.A.; Bodaghi, B.; Musset, L.; Soumelis, V.; Klatzmann, D.; Cacoub, P.; Saadoun, D. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin. Immunol., 2011, 128(3), 655-664.
67. Rodríguez-Rodríguez, L.; Castañeda, S.; Vázquez-Rodríguez, T.R.; Morado, I.C.; Gómez-Vaquero, C.; Marí-Alfonso, B.; Miranda-Filloy, J.A.; Narvaez, J.; Ortego-Centeno, N.; Vicente, E.F.; Blanco, R.; Amigo-Diaz, E.; Fernández-Gutiérrez, B.; Martin, J.; González-Gay, M.A. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis. Clin. Exp. Rheumatol., 2011, 29(1 Suppl 64), S12-S16.
68. Zhu, C.; Ma, J.; Liu, Y.; Tong, J.; Tian, J.; Chen, J.; Tang, X.; Xu, H.; Lu, L.; Wang, S. Increased Frequency of Follicular Helper T Cells in Patients with Autoimmune Thyroid Disease. J Clin. Endocrinol. Metab., 2012, 97(3), 943-950.
69. Jia, H.Y.; Zhang, Z.G.; Gu, X.J.; Guo, T.; Cui, B.; Ning, G.; Zhao, Y.J. Association between interleukin 21 and Graves' disease. Genet Mol. Res., 2011, 10(4), [Epub ahead of print].
70. Vollmer, T.L.; Liu, R.; Price, M.; Rhodes, S.; La Cava, A.; Shi, F.D. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol., 2005, 174(5), 2696-2701.
71. Liu, R.; Van Kaer, L.; La Cava, A.; Price, M.; Campagnolo, D.I.; Collins, M.; Young, D.A.; Vollmer, T.L.; Shi, F.D. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol., 2006, 176(9), 5247-5254.
72. Konforte, D.; Simard, N.; Paige, C.J. IL-21: an executor of B cell fate. J. Immunol., 2009, 182(4), 1781-1787.
73. Suto, A.; Nakajima, H.; Hirose, K.; Suzuki, K.; Kagami, S.; Seto, Y.; Hoshimoto, A.; Saito, Y.; Foster, D.C.; Iwamoto, I. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood, 2002, 100(13), 4565-4573.